Rosacea study: Acupuncture
Official title Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and Safety
ClinicalTrials.gov ID: NCT07296497
What this study is testing
- What it's testing
- This study is testing whether acupuncture can reduce facial redness and flushing in rosacea that does not improve with usual care.
- Who it's for
- You may be able to join if you have rosacea that has not gotten better with standard treatments.
- What's involved
- You will receive either real acupuncture or a pretend treatment that feels the same. You will visit the clinic several times for needle sessions and skin checks.
- Time commitment
- The study lasts several weeks and requires regular clinic visits for treatment and follow‑up.
You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients diagnosed with refractory rosacea, defined as those who have received at least 12 weeks of conventional oral medication (such as...
- Age between 18 and 65 years, inclusive, with no restriction on sex;
- Individuals who fully understand the purpose and significance of the study, voluntarily agree to participate, sign the informed consent form (ICF)...
You likely can't join if
- Women who are pregnant, breastfeeding, or planning to become pregnant in the near future;
- Patients with diabetes mellitus or moderate to severe systemic diseases affecting the liver, kidney, lung, or hematologic system;
- Patients with depression or other psychiatric disorders;
- Individuals with severe abnormal reactions to acupuncture (e.g., syncope during acupuncture, allergy to acupuncture needles);
- Patients with rosacea accompanied by nasal hypertrophy or other facial dermatoses (such as seborrheic dermatitis, eczema) or facial manifestations of...
- Individuals with a bleeding tendency or coagulation disorders, or with skin damage, infection, or other lesions at the acupuncture sites;
See the full eligibility criteria
- Patients diagnosed with refractory rosacea, defined as those who have received at least 12 weeks of conventional oral medication (such as doxycycline), with or without other treatments (e.g., topical medications or...
- Age between 18 and 65 years, inclusive, with no restriction on sex;
- Individuals who fully understand the purpose and significance of the study, voluntarily agree to participate, sign the informed consent form (ICF), and are willing to comply with all study procedures and follow-up...
- Women who are pregnant, breastfeeding, or planning to become pregnant in the near future;
- Patients with diabetes mellitus or moderate to severe systemic diseases affecting the liver, kidney, lung, or hematologic system;
- Patients with depression or other psychiatric disorders;
- Individuals with severe abnormal reactions to acupuncture (e.g., syncope during acupuncture, allergy to acupuncture needles);
- Patients with rosacea accompanied by nasal hypertrophy or other facial dermatoses (such as seborrheic dermatitis, eczema) or facial manifestations of other systemic diseases (such as dermatomyositis, systemic lupus...
- Individuals with a bleeding tendency or coagulation disorders, or with skin damage, infection, or other lesions at the acupuncture sites;
- Patients who discontinued oral antibiotics less than 1 month prior to enrollment; discontinued non-antibiotic oral medications less than 15 days prior (or isotretinoin less than 3 months prior)
- Patients who are expected to be unable to comply with follow-up requirements;
- Individuals who have participated in any other clinical trial within 1 month before screening (defined as having signed an informed consent form and received an investigational drug/device/placebo);
- Any other condition that, in the opinion of the investigator, makes the participant unsuitable for enrollment.
The study team makes the final eligibility decision.
Where it is enrolling
- Changsha, Hunan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Changsha, Hunan, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.